C-peptide in the vessel wall

Review of Diabetic Studies

Volumn 6, Issue 3, 2009, Pages 180-186

  Walcher, Daniel ^a   Marx, Nikolaus ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Arteriosclerosis; C peptide; Diabetes; Inflammation; Lipoprotein; Reactive oxygen species; Smooth muscle cell; Vascular cell

Indexed keywords

C PEPTIDE;

ARTERIOSCLEROSIS; ATHEROGENESIS; BLOOD VESSEL WALL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOTAXIS; DISEASE COURSE; HEART INFARCTION; HUMAN; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTERNALIZATION; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STROKE; VASCULAR SMOOTH MUSCLE;

EID: 76149092190     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.180     Document Type: Review

References (33)

1. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002. 287(19):2570-2581.
2. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R, Jörnvall H. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 2000. 278(5):E759-E768.
3. Kitamura T, Kimura K, Jung BD, Makondo K, Okamoto S, Canas X, Sakane N, Yoshida T, Saito M. Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxinsensitive G-protein. Biochem J 2001. 355(Pt 1):123-129.
4. Kitamura T, Kimura K, Jung BD, Makondo K, Sakane N, Yoshida T, Saito M. Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J 2002. 366(Pt 3):737-744.
5. Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindström P, Wahren J. Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 2003. 52(2):536-541.
6. Ekberg K, Brismar T, Johansson BL, Lindström P, Juntti-Berggren L, Norrby A, Berne C, Arnqvist HJ, Bolinder J, Wahren J. C-peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care 2007. 30(1):71-76.
7. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 2005. 20(3):532-538.
8. Sjöquist M, Huang W, Johansson BL. Effects of Cpeptide on renal function at the early stage of experimental diabetes. Kidney Int 1998. 54(3):758-764.
9. Wallerath T, Kunt T, Forst T, Closs EI, Lehmann R, Flohr T, Gabriel M, Schäfer D, Göpfert A, Pfützner A, Beyer J, Förstermann U. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 2003. 9(2):95-102.
10. Kamikawa A, Ishii T, Shimada K, Makondo K, Inanami O, Sakane N, Yoshida T, Saito M, Kimura K. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Diabetes Metab Res Rev 2008. 24(4):331-338.
11. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999. 340(2):115-126.
12. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005. 352(16):1685-1695.
13. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996. 7(5):330-335.
14. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 2006. 26(11):2421-2432.
15. Marx N. Diabetes und Arteriosklerose. Diabetes und Stoffwechsel 2003. 4:205-211.
16. Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation 2001. 103(13):1718-1720.
17. Trovati M, Anfossi G. Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. J Diabetes Complications 2002. 16:35-40.
18. Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes. Rev Cardiovasc Med 2006. 7:S25-S34.
19. Dandona P, Chaudhuri A, Mohanty P, Ghanim H. Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care 2007. 10: 511-517.
20. Marx N, Walcher D, Raichle C, Aleksic M, Bach H, Grüb M, Hombach V, Libby P, Zieske A, Homma S, Strong J. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol 2004. 24(3):540-545.
21. Walcher D, Aleksic M, Jerg V, Hombach V, Zieske A, Homma S, Strong J, Marx N. C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes 2004. 53(7):1664-1670.
22. Aleksic M, Walcher D, Giehl K, Bach H, Grüb M, Durst R, Hombach V, Marx N. Signalling processes involved in C-peptide-induced chemotaxis of CD4-positive lymphocytes. Cell Mol Life Sci 2009. 66(11-12):1974-1984.
23. Kukhtina NB, Arefieva TI, Krasnikova TL. Intracellular signal cascade in CD4+ T-lymphocyte migration stimulated by interferon-gamma-inducible protein-10. Biochemistry (Mosc) 2005. 70:652-656.
24. Al-Rasheed NM, Chana RS, Baines RJ, Willars GB, Brunskill NJ. Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and Cpeptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity. J Biol Chem 2004. 279(48):49747-49754.
25. Lindahl E, Nyman U, Melles E, Sigmundsson K, Stahlberg M, Wahren J, Obrink B, Shafqat J, Joseph B, Jörnvall H. Cellular internalization of proinsulin C-peptide. Cell Mol Life Sci 2007. 64(4):479-486.
26. Luppi P, Geng X, Cifarelli V, Drain P, Trucco M. Cpeptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes. Diabetologia 2009. 52(10):2218-2228.
27. Bittl JA. Advances in coronary angioplasty. N Engl J Med 1996. 335(17):1290-1302.
28. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. One year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004. 109(16):1942-1947.
29. Kobayashi Y, Naruse K, Hamada Y, Nakashima E, Kato K, Akiyama N, Kamiya H, Watarai A, Nakae M, Oiso Y, Nakamura J. Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions. Diabetologia 2005. 48:2396-2401.
30. Walcher D, Babiak C, Poletek P, Rosenkranz S, Bach H, Betz S, Durst R, Grüb M, Hombach V, Strong J, Marx N. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res 2006. 99(11):1181-1187.
31. Cho HM, Choi SH, Hwang KC, Oh SY, Kim HG, Yoon DH, Choi MA, Lim S, Song H, Jang Y, Kim TW. The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL. Mol Cells 2005. 19(1):60-66.
32. Beijersbergen RL, Bernards R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta 1996. 1287(2-3):103-120.
33. Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000. 2(4):E65-E67.